When farmers rely on veterinary medicines to protect animal health, an extensive regulatory system works behind the scenes to ensure these products meet the required standards. From registration and licensing […]
Edinburgh, UK (September 16, 2026) – GALVmed is pleased to announce Dr Johan Dreesen as the new Chair of its Board of Trustees. Johan takes over from Dr Isabelle Dieuzy-Labaye who retired […]
Healthy Livestock, Better Lives provides a comprehensive overview of GALVmed’s work since our inception, highlighting how our programmes, partnerships and innovations are helping to transform animal health. It brings together […]
A new series presented by WOAH, produced for WOAH by BBC StoryWorks Commercial Productions, explores the connections between animals, people and the environments we share, and how these relationships are […]
Nairobi, Kenya, June 2nd 2026 – In April 2026, the AgResults Foot and Mouth Disease (FMD) Vaccine Challenge Project, managed by GALVmed, reached a significant milestone with Boehringer Ingelheim becoming […]
A novel three-in-one vaccine is now available in Kenya to help livestock farmers protect their animals against multiple diseases with a single dose. April 22, Diani, KENYA – A […]
GALVmed has entered into a new agreement with the University of Toronto, and Engineered Antigens Inc, a spinoff company by University of Calgary and University of Toronto, as well as […]
Stakeholders meet in Nairobi to expand access to affordable livestock disease testing Nairobi, Kenya, 01 April 2026: Livestock diseases continue to pose a significant threat to farmers’ livelihoods, food security […]
We’re excited to share GALVmed’s 2025 Year in Review, an overview of our accomplishments and the progress made throughout the year in advancing our mission. The review reflects a year […]
Small-scale livestock producers across sub-Saharan Africa continue to operate in an increasingly complex environment. Disease pressures remain high, climate variability is intensifying risk, and public animal health systems are often […]
